Drug intelligence / Profile preview

insulin degludec + insulin lispro

Development stage
Preclinical
Lead developer
Novo Nordisk
Modality
Recombinant Proteins and Enzymes
Administration
Subcutaneous
01

Overview

Insulin degludec + insulin lispro is a combination therapy that utilizes two different insulin formulations to provide comprehensive glycemic control in diabetes. Insulin degludec is a long-acting basal insulin analog that provides a steady background insulin level for approximately 24 hours, helping to control blood glucose during fasting periods. Insulin lispro is a rapid-acting insulin analog with onset of action in 10-15 minutes, peak activity at about 60 minutes, and duration of 4-5 hours, designed to mimic postprandial insulin spikes. This combination allows for both basal glucose control and mealtime coverage in patients with diabetes mellitus.

02

Targets

INSR (Insulin receptor)

Beyond the preview

Go deeper on insulin degludec + insulin lispro.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on insulin degludec + insulin lispro.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call